Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm

Calliditas Therapeutics AB (publ) is set to be delisted from Nasdaq Stockholm.

Rhea-AI Summary

Calliditas Therapeutics AB (publ) is set to be delisted from Nasdaq Stockholm. The stock exchange has made the decision, with the final trading day scheduled for Thursday, October 10, 2024. This significant development was announced on September 16, 2024, at 15:30 CET. For investors and stakeholders seeking more information, Åsa Hillsten, the Head of IR & Sustainability at Calliditas, has been designated as the contact person.

Positive

• None.

Negative

• Delisting from Nasdaq Stockholm
• Last trading day on October 10, 2024

Argus Session date unavailable

+1.88% session move Open Argus

Details

News Market Reaction – CALT

The recorded move for CALT in the trading session of this news was +1.88%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STOCKHOLM, Sept. 16, 2024 /PRNewswire/ -- Nasdaq Stockholm has decided that Calliditas Therapeutics AB (publ) will be delisted from Nasdaq Stockholm. The last day of trading in the share will be on Thursday, October 10, 2024.

For further information, please contact:

Åsa Hillsten, Head of IR & Sustainability, Calliditas

Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com

The information was sent for publication, through the agency of the contact person set out above, on September 16, 2024 at 15:30 CET.

About Calliditas

Calliditas Therapeutics is a biopharma company headquartered in Stockholm, Sweden, focused on identifying, developing, and commercializing novel treatments in orphan indications with significant unmet medical needs. Calliditas' common shares are listed on Nasdaq Stockholm (ticker: CALTX). Visit Calliditas.com for further information.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/calliditas-therapeutics/r/delisting-of-calliditas-therapeutics-ab--publ--from-nasdaq-stockholm,c4038098

The following files are available for download:

https://mb.cision.com/Main/16574/4038098/3002835.pdf

Calliditas- announcing date for de-listing (eng)

View original content:https://www.prnewswire.com/news-releases/delisting-of-calliditas-therapeutics-ab-publ-from-nasdaq-stockholm-302249090.html

SOURCE Calliditas Therapeutics

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Calliditas Therapeutics (CALT) be delisted from Nasdaq Stockholm?

Calliditas Therapeutics (CALT) will be delisted from Nasdaq Stockholm on October 10, 2024, which is the last day of trading for the stock on this exchange.

What is the reason for Calliditas Therapeutics (CALT) being delisted from Nasdaq Stockholm?

The press release does not provide a specific reason for the delisting of Calliditas Therapeutics (CALT) from Nasdaq Stockholm. It only states that Nasdaq Stockholm has made the decision to delist the company.

Who should investors contact for more information about Calliditas Therapeutics (CALT) delisting?

Investors can contact Åsa Hillsten, Head of IR & Sustainability at Calliditas, for more information about the delisting. She can be reached at +46 76 403 35 43 or asa.hillsten@calliditas.com.

What are the implications for shareholders of Calliditas Therapeutics (CALT) after the delisting?

The press release doesn't provide specific information about the implications for shareholders. Typically, delisting can affect stock liquidity and trading options. Shareholders should contact the company or their financial advisors for guidance.